| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.098 | 0.4 |